A 12 Week, Multi-center, Randomized, Double Blinded, Placebo-controlled, Parallel Group, Fixed Dose Study to Assess the Efficacy and Safety of SK3530 on Erectile Dysfunction in Patients With Diabetes Mellitus
Phase of Trial: Phase III
Latest Information Update: 17 Apr 2013
At a glance
- Drugs Mirodenafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors SK Chemicals
- 14 Sep 2010 Status changed from recruiting to completed according to publication of results in the Journal of Sexual Medicine.
- 01 Aug 2010 Results were published in the Journal of Sexual Medicine.
- 19 Mar 2009 Results reported at the 24th Congress of the European Association of Urology (EAU), 2009.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History